TriReme Medical's Japanese partner Century Medical has received Shonin approval for the Glider PTCA catheter, which is used to treat the stenotic portion of coronary arteries or bypass grafts to improve the myocardial perfusion.
Used to treat cases of bifurcations and highly stenosed lesions, Glider PTCA catheter, which the company claims, is the only torqueable PTCA catheter and consists of a combination of a skived tip and a braided shaft.
TriReme CEO and president Eitan Konstantino said this milestone represents yet another concrete step in the company's strategic focus on the important Asian markets.
Century Medical CEO and president Akira Hoshino said with the company's technology, Glider is designed to cross through tight lesions and provide improved outcomes.
"Glider represents the first product, with others to follow, in our strategic partnership that will allow us to bring TriReme's cutting edge and high quality devices to Japan," Hoshino added.
